glp-1 stomach cramps and diarrhea on a is common, predictable, manageable. Here's what's driving it and what to do about it. #obesitymedicine #womenshealth #obesitydoctor​​​​​​​​​​​​​​​​ Managing GLP-1 therapy side effects

Insert at a 90-degree angle in areas with sufficient subcutaneous fat like the abdomen

Insulin resistance alters nutrient partitioning, potentially directing fewer resources toward muscle preservation

doi: 10.1371/journal.pone.0109477

Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort

(Accessed on 22

(2020) 18(1):5768.e5